Valion Bio’s Entolimod Enters U.S.-Funded GI-ARS Efficacy Study
NIAID and AFRRI will run a fully funded efficacy study of Entolimod in a GI-ARS mouse model. Top-line results are expected in early December, following positive safety findings.
NIAID and AFRRI will run a fully funded efficacy study of Entolimod in a GI-ARS mouse model. Top-line results are expected in early December, following positive safety findings.